Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Anika Therapeutics (ANIK) Other Operating Expenses: 2009-2021

Historic Other Operating Expenses for Anika Therapeutics (ANIK) over the last 12 years, with Dec 2021 value amounting to -$21.1 million.

  • Anika Therapeutics' Other Operating Expenses rose 105.27% to $825,000 in Q4 2021 from the same period last year, while for Dec 2021 it was $6.7 million, marking a year-over-year increase of 129.34%. This contributed to the annual value of -$21.1 million for FY2021, which is 8.22% up from last year.
  • Per Anika Therapeutics' latest filing, its Other Operating Expenses stood at -$21.1 million for FY2021, which was up 8.22% from -$23.0 million recorded in FY2020.
  • In the past 5 years, Anika Therapeutics' Other Operating Expenses registered a high of $27.4 million during FY2017, and its lowest value of -$23.0 million during FY2020.
  • In the last 3 years, Anika Therapeutics' Other Operating Expenses had a median value of -$21.1 million in 2021 and averaged -$12.3 million.
  • Per our database at Business Quant, Anika Therapeutics' Other Operating Expenses grew by 13.89% in 2017 and then plummeted by 421.72% in 2020.
  • Anika Therapeutics' Other Operating Expenses (Yearly) stood at $27.4 million in 2017, then reached $7.1 million in 2019, then plummeted by 421.72% to -$23.0 million in 2020, then rose by 8.22% to -$21.1 million in 2021.